Dispersome(R) Technology

Dispersome(R) Technology

Products
Dispersome(R) Technology
Dispersome(R) Technology

Information

Dispersome(R)️ - A green technology for drugs The Dispersome(R) technology uses high quality whey protein, an environmentally friendly by-product from cheese production, to improve the solubility and bioavailability of poorly soluble drugs. To watch explanatory Dispersome(R) video: https://youtu.be/zX4-1-JBXjk
All categories
Biopharmaceutical ProductsExcipientsFinished Dosage FormsTabletsAcademia and Research CentresPharmaceutical Machinery & TechnologyBioavailability enhancementProducts
Main Categories
Biopharmaceutical ProductsExcipientsFinished Dosage FormsPharmaceutical Machinery & Technology
ZERION PHARMAZerion Pharma A/S is a pharmaceutical company aspiring to transform the pharmaceutical landscape for the formulation of poorly soluble drugs that are currently not reaching their therapeutic potential. The company was established in 2019 as a spinout from the University of Copenhagen based on a decade of research. Zerion Pharma A/S has pioneered the Dispersome(R) technology that greatly enhances the solubility of poorly soluble, oral drugs and improves bioavailability and therapeutic options for patients.

Log in

See all the content and easy-to-use features by logging in or registering!